MIR4287: A Potential Drug Target and Biomarker (G100422828)

MIR4287: A Potential Drug Target and Biomarker

MIR4287, a gene encoding a protein known as mir4287, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Its unique structure and function have made it an attractive target for researchers to investigate, and its potential as a drug may have significant implications for the treatment of these diseases.

The MIR4287 gene was identified in the database of the National Library of Medicine as having the highest number of citations and publications, indicating that it has been studied extensively. The protein produced by the MIR4287 gene has been shown to have various functions in various organisms, including the regulation of cell growth, differentiation, and survival.

One of the most significant functions of MIR4287 is its role in the regulation of cell survival. Studies have shown that MIR4287 plays a role in the regulation of cell cycle progression, cell survival, and apoptosis. It has been shown to promote the growth and survival of cancer cells, and to inhibit the death of cancer cells under stress. This suggests that MIR4287 may be a potential drug target for cancer treatment.

MIR4287 has also been shown to play a role in the regulation of neurodegenerative disorders. Studies have shown that MIR4287 is involved in the regulation of neurotransmitter synthesis and release, as well as the regulation of neurotransmitter receptors. It has been shown to protect against neurotoxins and to modulate the activity of neurotransmitter receptors. This suggests that MIR4287 may be a potential drug target for neurodegenerative disorders.

MIR4287 has also been shown to play a role in the regulation of autoimmune diseases. Studies have shown that MIR4287 is involved in the regulation of immune cell function and the regulation of inflammation. It has been shown to protect against the development of autoimmune diseases and to modulate the activity of immune cells. This suggests that MIR4287 may be a potential drug target for autoimmune diseases.

In addition to its potential drug target properties, MIR4287 has also been shown to have potential as a biomarker. Studies have shown that MIR4287 can be used as a protein biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. This suggests that MIR4287 may have significant implications for the diagnosis and treatment of these diseases.

Overall, MIR4287 is a protein that has significant potential as a drug target and biomarker. Its unique structure and function make it an attractive target for researchers to investigate, and its potential as a drug or biomarker may have significant implications for the treatment of various diseases. Further research is needed to fully understand the functions of MIR4287 and its potential as a drug or biomarker.

Protein Name: MicroRNA 4287

The "MIR4287 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4287 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4288 | MIR4289 | MIR429 | MIR4290 | MIR4291 | MIR4292 | MIR4293 | MIR4294 | MIR4295 | MIR4296 | MIR4297 | MIR4298 | MIR4299 | MIR4300 | MIR4300HG | MIR4301 | MIR4302 | MIR4303 | MIR4304 | MIR4305 | MIR4306 | MIR4307 | MIR4308 | MIR4309 | MIR431 | MIR4310 | MIR4311 | MIR4312 | MIR4313 | MIR4314 | MIR4315-1 | MIR4315-2 | MIR4316 | MIR4317 | MIR4318 | MIR4319 | MIR432 | MIR4320 | MIR4321 | MIR4322 | MIR4323 | MIR4324 | MIR4325 | MIR4326 | MIR4327 | MIR4328 | MIR4329 | MIR433 | MIR4330 | MIR4418 | MIR4420 | MIR4423 | MIR4425 | MIR4427 | MIR4428 | MIR4429 | MIR4430 | MIR4431 | MIR4432 | MIR4432HG | MIR4433A | MIR4433B | MIR4435-1 | MIR4435-2 | MIR4435-2HG | MIR4436A | MIR4436B1 | MIR4436B2 | MIR4437 | MIR4440 | MIR4441 | MIR4442 | MIR4443 | MIR4444-1 | MIR4444-2 | MIR4445 | MIR4446 | MIR4447 | MIR4448 | MIR4449 | MIR4450 | MIR4451 | MIR4453 | MIR4453HG | MIR4454 | MIR4455 | MIR4456 | MIR4457 | MIR4458 | MIR4458HG | MIR4463 | MIR4465 | MIR4466 | MIR4467 | MIR4468 | MIR4469 | MIR4470 | MIR4472-1 | MIR4472-2 | MIR4474